Global Therapeutic Radiopharmaceuticals Supply, Demand and Key Producers, 2023-2029

Global Therapeutic Radiopharmaceuticals Supply, Demand and Key Producers, 2023-2029

Page: 113

Published Date: 09 Aug 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Therapeutic Radiopharmaceuticals market size is expected to reach $ 4687.5 million by 2029, rising at a market growth of 14.5% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

This report studies the global Therapeutic Radiopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Therapeutic Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Radiopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Therapeutic Radiopharmaceuticals total production and demand, 2018-2029, (K Units)
Global Therapeutic Radiopharmaceuticals total production value, 2018-2029, (USD Million)
Global Therapeutic Radiopharmaceuticals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Therapeutic Radiopharmaceuticals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Therapeutic Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Therapeutic Radiopharmaceuticals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Therapeutic Radiopharmaceuticals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Therapeutic Radiopharmaceuticals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Therapeutic Radiopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus and Aurobindo Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Radiopharmaceuticals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Therapeutic Radiopharmaceuticals Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Therapeutic Radiopharmaceuticals Market, Segmentation by Type
Radium-223
Lutetium-177
Iodine-131
Other

Global Therapeutic Radiopharmaceuticals Market, Segmentation by Application
Thyroid
Bone Metastasis
Lymphoma
Other

Companies Profiled:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma

Key Questions Answered
1. How big is the global Therapeutic Radiopharmaceuticals market?
2. What is the demand of the global Therapeutic Radiopharmaceuticals market?
3. What is the year over year growth of the global Therapeutic Radiopharmaceuticals market?
4. What is the production and production value of the global Therapeutic Radiopharmaceuticals market?
5. Who are the key producers in the global Therapeutic Radiopharmaceuticals market?
btl

Table of Contents

1 Supply Summary
1.1 Therapeutic Radiopharmaceuticals Introduction
1.2 World Therapeutic Radiopharmaceuticals Supply & Forecast
1.2.1 World Therapeutic Radiopharmaceuticals Production Value (2018 & 2022 & 2029)
1.2.2 World Therapeutic Radiopharmaceuticals Production (2018-2029)
1.2.3 World Therapeutic Radiopharmaceuticals Pricing Trends (2018-2029)
1.3 World Therapeutic Radiopharmaceuticals Production by Region (Based on Production Site)
1.3.1 World Therapeutic Radiopharmaceuticals Production Value by Region (2018-2029)
1.3.2 World Therapeutic Radiopharmaceuticals Production by Region (2018-2029)
1.3.3 World Therapeutic Radiopharmaceuticals Average Price by Region (2018-2029)
1.3.4 North America Therapeutic Radiopharmaceuticals Production (2018-2029)
1.3.5 Europe Therapeutic Radiopharmaceuticals Production (2018-2029)
1.3.6 China Therapeutic Radiopharmaceuticals Production (2018-2029)
1.3.7 Japan Therapeutic Radiopharmaceuticals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Therapeutic Radiopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Therapeutic Radiopharmaceuticals Major Market Trends

2 Demand Summary
2.1 World Therapeutic Radiopharmaceuticals Demand (2018-2029)
2.2 World Therapeutic Radiopharmaceuticals Consumption by Region
2.2.1 World Therapeutic Radiopharmaceuticals Consumption by Region (2018-2023)
2.2.2 World Therapeutic Radiopharmaceuticals Consumption Forecast by Region (2024-2029)
2.3 United States Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.4 China Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.5 Europe Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.6 Japan Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.7 South Korea Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.8 ASEAN Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.9 India Therapeutic Radiopharmaceuticals Consumption (2018-2029)

3 World Therapeutic Radiopharmaceuticals Manufacturers Competitive Analysis
3.1 World Therapeutic Radiopharmaceuticals Production Value by Manufacturer (2018-2023)
3.2 World Therapeutic Radiopharmaceuticals Production by Manufacturer (2018-2023)
3.3 World Therapeutic Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 Therapeutic Radiopharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Therapeutic Radiopharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Therapeutic Radiopharmaceuticals in 2022
3.5.3 Global Concentration Ratios (CR8) for Therapeutic Radiopharmaceuticals in 2022
3.6 Therapeutic Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 Therapeutic Radiopharmaceuticals Market: Region Footprint
3.6.2 Therapeutic Radiopharmaceuticals Market: Company Product Type Footprint
3.6.3 Therapeutic Radiopharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Therapeutic Radiopharmaceuticals Production Value Comparison
4.1.1 United States VS China: Therapeutic Radiopharmaceuticals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Therapeutic Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Therapeutic Radiopharmaceuticals Production Comparison
4.2.1 United States VS China: Therapeutic Radiopharmaceuticals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Therapeutic Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Therapeutic Radiopharmaceuticals Consumption Comparison
4.3.1 United States VS China: Therapeutic Radiopharmaceuticals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Therapeutic Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Therapeutic Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Value (2018-2023)
4.4.3 United States Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023)
4.5 China Based Therapeutic Radiopharmaceuticals Manufacturers and Market Share
4.5.1 China Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Therapeutic Radiopharmaceuticals Production Value (2018-2023)
4.5.3 China Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023)
4.6 Rest of World Based Therapeutic Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023)

5 Market Analysis by Type
5.1 World Therapeutic Radiopharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Radium-223
5.2.2 Lutetium-177
5.2.3 Iodine-131
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Therapeutic Radiopharmaceuticals Production by Type (2018-2029)
5.3.2 World Therapeutic Radiopharmaceuticals Production Value by Type (2018-2029)
5.3.3 World Therapeutic Radiopharmaceuticals Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Therapeutic Radiopharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Thyroid
6.2.2 Bone Metastasis
6.2.3 Lymphoma
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Therapeutic Radiopharmaceuticals Production by Application (2018-2029)
6.3.2 World Therapeutic Radiopharmaceuticals Production Value by Application (2018-2029)
6.3.3 World Therapeutic Radiopharmaceuticals Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Therapeutic Radiopharmaceuticals Product and Services
7.1.4 Bayer Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Therapeutic Radiopharmaceuticals Product and Services
7.2.4 Novartis Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Details
7.3.2 China Isotope & Radiation Major Business
7.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
7.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 China Isotope & Radiation Recent Developments/Updates
7.3.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.4 Dongcheng
7.4.1 Dongcheng Details
7.4.2 Dongcheng Major Business
7.4.3 Dongcheng Therapeutic Radiopharmaceuticals Product and Services
7.4.4 Dongcheng Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Dongcheng Recent Developments/Updates
7.4.6 Dongcheng Competitive Strengths & Weaknesses
7.5 Q BioMed
7.5.1 Q BioMed Details
7.5.2 Q BioMed Major Business
7.5.3 Q BioMed Therapeutic Radiopharmaceuticals Product and Services
7.5.4 Q BioMed Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Q BioMed Recent Developments/Updates
7.5.6 Q BioMed Competitive Strengths & Weaknesses
7.6 Curium Pharmaceuticals
7.6.1 Curium Pharmaceuticals Details
7.6.2 Curium Pharmaceuticals Major Business
7.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
7.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Curium Pharmaceuticals Recent Developments/Updates
7.6.6 Curium Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Jubilant Radiopharma
7.7.1 Jubilant Radiopharma Details
7.7.2 Jubilant Radiopharma Major Business
7.7.3 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product and Services
7.7.4 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Jubilant Radiopharma Recent Developments/Updates
7.7.6 Jubilant Radiopharma Competitive Strengths & Weaknesses
7.8 Lantheus
7.8.1 Lantheus Details
7.8.2 Lantheus Major Business
7.8.3 Lantheus Therapeutic Radiopharmaceuticals Product and Services
7.8.4 Lantheus Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Lantheus Recent Developments/Updates
7.8.6 Lantheus Competitive Strengths & Weaknesses
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Details
7.9.2 Aurobindo Pharma Major Business
7.9.3 Aurobindo Pharma Therapeutic Radiopharmaceuticals Product and Services
7.9.4 Aurobindo Pharma Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Aurobindo Pharma Recent Developments/Updates
7.9.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.10 International Isotopes
7.10.1 International Isotopes Details
7.10.2 International Isotopes Major Business
7.10.3 International Isotopes Therapeutic Radiopharmaceuticals Product and Services
7.10.4 International Isotopes Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 International Isotopes Recent Developments/Updates
7.10.6 International Isotopes Competitive Strengths & Weaknesses
7.11 Mundipharma
7.11.1 Mundipharma Details
7.11.2 Mundipharma Major Business
7.11.3 Mundipharma Therapeutic Radiopharmaceuticals Product and Services
7.11.4 Mundipharma Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Mundipharma Recent Developments/Updates
7.11.6 Mundipharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Therapeutic Radiopharmaceuticals Industry Chain
8.2 Therapeutic Radiopharmaceuticals Upstream Analysis
8.2.1 Therapeutic Radiopharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of Therapeutic Radiopharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Therapeutic Radiopharmaceuticals Production Mode
8.6 Therapeutic Radiopharmaceuticals Procurement Model
8.7 Therapeutic Radiopharmaceuticals Industry Sales Model and Sales Channels
8.7.1 Therapeutic Radiopharmaceuticals Sales Model
8.7.2 Therapeutic Radiopharmaceuticals Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Therapeutic Radiopharmaceuticals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Therapeutic Radiopharmaceuticals Production Value by Region (2018-2023) & (USD Million)
Table 3. World Therapeutic Radiopharmaceuticals Production Value by Region (2024-2029) & (USD Million)
Table 4. World Therapeutic Radiopharmaceuticals Production Value Market Share by Region (2018-2023)
Table 5. World Therapeutic Radiopharmaceuticals Production Value Market Share by Region (2024-2029)
Table 6. World Therapeutic Radiopharmaceuticals Production by Region (2018-2023) & (K Units)
Table 7. World Therapeutic Radiopharmaceuticals Production by Region (2024-2029) & (K Units)
Table 8. World Therapeutic Radiopharmaceuticals Production Market Share by Region (2018-2023)
Table 9. World Therapeutic Radiopharmaceuticals Production Market Share by Region (2024-2029)
Table 10. World Therapeutic Radiopharmaceuticals Average Price by Region (2018-2023) & (USD/Unit)
Table 11. World Therapeutic Radiopharmaceuticals Average Price by Region (2024-2029) & (USD/Unit)
Table 12. Therapeutic Radiopharmaceuticals Major Market Trends
Table 13. World Therapeutic Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Therapeutic Radiopharmaceuticals Consumption by Region (2018-2023) & (K Units)
Table 15. World Therapeutic Radiopharmaceuticals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Therapeutic Radiopharmaceuticals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Therapeutic Radiopharmaceuticals Producers in 2022
Table 18. World Therapeutic Radiopharmaceuticals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Therapeutic Radiopharmaceuticals Producers in 2022
Table 20. World Therapeutic Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 21. Global Therapeutic Radiopharmaceuticals Company Evaluation Quadrant
Table 22. World Therapeutic Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Therapeutic Radiopharmaceuticals Production Site of Key Manufacturer
Table 24. Therapeutic Radiopharmaceuticals Market: Company Product Type Footprint
Table 25. Therapeutic Radiopharmaceuticals Market: Company Product Application Footprint
Table 26. Therapeutic Radiopharmaceuticals Competitive Factors
Table 27. Therapeutic Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. Therapeutic Radiopharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China Therapeutic Radiopharmaceuticals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Therapeutic Radiopharmaceuticals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Therapeutic Radiopharmaceuticals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share (2018-2023)
Table 37. China Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share (2018-2023)
Table 42. Rest of World Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share (2018-2023)
Table 47. World Therapeutic Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Therapeutic Radiopharmaceuticals Production by Type (2018-2023) & (K Units)
Table 49. World Therapeutic Radiopharmaceuticals Production by Type (2024-2029) & (K Units)
Table 50. World Therapeutic Radiopharmaceuticals Production Value by Type (2018-2023) & (USD Million)
Table 51. World Therapeutic Radiopharmaceuticals Production Value by Type (2024-2029) & (USD Million)
Table 52. World Therapeutic Radiopharmaceuticals Average Price by Type (2018-2023) & (USD/Unit)
Table 53. World Therapeutic Radiopharmaceuticals Average Price by Type (2024-2029) & (USD/Unit)
Table 54. World Therapeutic Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Therapeutic Radiopharmaceuticals Production by Application (2018-2023) & (K Units)
Table 56. World Therapeutic Radiopharmaceuticals Production by Application (2024-2029) & (K Units)
Table 57. World Therapeutic Radiopharmaceuticals Production Value by Application (2018-2023) & (USD Million)
Table 58. World Therapeutic Radiopharmaceuticals Production Value by Application (2024-2029) & (USD Million)
Table 59. World Therapeutic Radiopharmaceuticals Average Price by Application (2018-2023) & (USD/Unit)
Table 60. World Therapeutic Radiopharmaceuticals Average Price by Application (2024-2029) & (USD/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Therapeutic Radiopharmaceuticals Product and Services
Table 64. Bayer Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Therapeutic Radiopharmaceuticals Product and Services
Table 70. Novartis Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 74. China Isotope & Radiation Major Business
Table 75. China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
Table 76. China Isotope & Radiation Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. China Isotope & Radiation Recent Developments/Updates
Table 78. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 79. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 80. Dongcheng Major Business
Table 81. Dongcheng Therapeutic Radiopharmaceuticals Product and Services
Table 82. Dongcheng Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Dongcheng Recent Developments/Updates
Table 84. Dongcheng Competitive Strengths & Weaknesses
Table 85. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 86. Q BioMed Major Business
Table 87. Q BioMed Therapeutic Radiopharmaceuticals Product and Services
Table 88. Q BioMed Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Q BioMed Recent Developments/Updates
Table 90. Q BioMed Competitive Strengths & Weaknesses
Table 91. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Curium Pharmaceuticals Major Business
Table 93. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 94. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Curium Pharmaceuticals Recent Developments/Updates
Table 96. Curium Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Jubilant Radiopharma Basic Information, Manufacturing Base and Competitors
Table 98. Jubilant Radiopharma Major Business
Table 99. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product and Services
Table 100. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Jubilant Radiopharma Recent Developments/Updates
Table 102. Jubilant Radiopharma Competitive Strengths & Weaknesses
Table 103. Lantheus Basic Information, Manufacturing Base and Competitors
Table 104. Lantheus Major Business
Table 105. Lantheus Therapeutic Radiopharmaceuticals Product and Services
Table 106. Lantheus Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Lantheus Recent Developments/Updates
Table 108. Lantheus Competitive Strengths & Weaknesses
Table 109. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Aurobindo Pharma Major Business
Table 111. Aurobindo Pharma Therapeutic Radiopharmaceuticals Product and Services
Table 112. Aurobindo Pharma Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Aurobindo Pharma Recent Developments/Updates
Table 114. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 115. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 116. International Isotopes Major Business
Table 117. International Isotopes Therapeutic Radiopharmaceuticals Product and Services
Table 118. International Isotopes Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. International Isotopes Recent Developments/Updates
Table 120. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 121. Mundipharma Major Business
Table 122. Mundipharma Therapeutic Radiopharmaceuticals Product and Services
Table 123. Mundipharma Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Therapeutic Radiopharmaceuticals Upstream (Raw Materials)
Table 125. Therapeutic Radiopharmaceuticals Typical Customers
Table 126. Therapeutic Radiopharmaceuticals Typical Distributors
List of Figure
Figure 1. Therapeutic Radiopharmaceuticals Picture
Figure 2. World Therapeutic Radiopharmaceuticals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Therapeutic Radiopharmaceuticals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 5. World Therapeutic Radiopharmaceuticals Average Price (2018-2029) & (USD/Unit)
Figure 6. World Therapeutic Radiopharmaceuticals Production Value Market Share by Region (2018-2029)
Figure 7. World Therapeutic Radiopharmaceuticals Production Market Share by Region (2018-2029)
Figure 8. North America Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 9. Europe Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 10. China Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 11. Japan Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 12. Therapeutic Radiopharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 15. World Therapeutic Radiopharmaceuticals Consumption Market Share by Region (2018-2029)
Figure 16. United States Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 17. China Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 18. Europe Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 19. Japan Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 20. South Korea Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 22. India Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Therapeutic Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Therapeutic Radiopharmaceuticals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Therapeutic Radiopharmaceuticals Markets in 2022
Figure 26. United States VS China: Therapeutic Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Therapeutic Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Therapeutic Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share 2022
Figure 30. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share 2022
Figure 32. World Therapeutic Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Therapeutic Radiopharmaceuticals Production Value Market Share by Type in 2022
Figure 34. Radium-223
Figure 35. Lutetium-177
Figure 36. Iodine-131
Figure 37. Other
Figure 38. World Therapeutic Radiopharmaceuticals Production Market Share by Type (2018-2029)
Figure 39. World Therapeutic Radiopharmaceuticals Production Value Market Share by Type (2018-2029)
Figure 40. World Therapeutic Radiopharmaceuticals Average Price by Type (2018-2029) & (USD/Unit)
Figure 41. World Therapeutic Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Therapeutic Radiopharmaceuticals Production Value Market Share by Application in 2022
Figure 43. Thyroid
Figure 44. Bone Metastasis
Figure 45. Lymphoma
Figure 46. Other
Figure 47. World Therapeutic Radiopharmaceuticals Production Market Share by Application (2018-2029)
Figure 48. World Therapeutic Radiopharmaceuticals Production Value Market Share by Application (2018-2029)
Figure 49. World Therapeutic Radiopharmaceuticals Average Price by Application (2018-2029) & (USD/Unit)
Figure 50. Therapeutic Radiopharmaceuticals Industry Chain
Figure 51. Therapeutic Radiopharmaceuticals Procurement Model
Figure 52. Therapeutic Radiopharmaceuticals Sales Model
Figure 53. Therapeutic Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Therapeutic Radiopharmaceuticals Supply, Demand and Key Producers, 2023-2029

Global Therapeutic Radiopharmaceuticals Supply, Demand and Key Producers, 2023-2029

Page: 113

Published Date: 09 Aug 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Therapeutic Radiopharmaceuticals market size is expected to reach $ 4687.5 million by 2029, rising at a market growth of 14.5% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

This report studies the global Therapeutic Radiopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Therapeutic Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Radiopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Therapeutic Radiopharmaceuticals total production and demand, 2018-2029, (K Units)
Global Therapeutic Radiopharmaceuticals total production value, 2018-2029, (USD Million)
Global Therapeutic Radiopharmaceuticals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Therapeutic Radiopharmaceuticals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Therapeutic Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Therapeutic Radiopharmaceuticals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Therapeutic Radiopharmaceuticals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Therapeutic Radiopharmaceuticals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Therapeutic Radiopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus and Aurobindo Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Radiopharmaceuticals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Therapeutic Radiopharmaceuticals Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Therapeutic Radiopharmaceuticals Market, Segmentation by Type
Radium-223
Lutetium-177
Iodine-131
Other

Global Therapeutic Radiopharmaceuticals Market, Segmentation by Application
Thyroid
Bone Metastasis
Lymphoma
Other

Companies Profiled:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma

Key Questions Answered
1. How big is the global Therapeutic Radiopharmaceuticals market?
2. What is the demand of the global Therapeutic Radiopharmaceuticals market?
3. What is the year over year growth of the global Therapeutic Radiopharmaceuticals market?
4. What is the production and production value of the global Therapeutic Radiopharmaceuticals market?
5. Who are the key producers in the global Therapeutic Radiopharmaceuticals market?
btl

Table of Contents

1 Supply Summary
1.1 Therapeutic Radiopharmaceuticals Introduction
1.2 World Therapeutic Radiopharmaceuticals Supply & Forecast
1.2.1 World Therapeutic Radiopharmaceuticals Production Value (2018 & 2022 & 2029)
1.2.2 World Therapeutic Radiopharmaceuticals Production (2018-2029)
1.2.3 World Therapeutic Radiopharmaceuticals Pricing Trends (2018-2029)
1.3 World Therapeutic Radiopharmaceuticals Production by Region (Based on Production Site)
1.3.1 World Therapeutic Radiopharmaceuticals Production Value by Region (2018-2029)
1.3.2 World Therapeutic Radiopharmaceuticals Production by Region (2018-2029)
1.3.3 World Therapeutic Radiopharmaceuticals Average Price by Region (2018-2029)
1.3.4 North America Therapeutic Radiopharmaceuticals Production (2018-2029)
1.3.5 Europe Therapeutic Radiopharmaceuticals Production (2018-2029)
1.3.6 China Therapeutic Radiopharmaceuticals Production (2018-2029)
1.3.7 Japan Therapeutic Radiopharmaceuticals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Therapeutic Radiopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Therapeutic Radiopharmaceuticals Major Market Trends

2 Demand Summary
2.1 World Therapeutic Radiopharmaceuticals Demand (2018-2029)
2.2 World Therapeutic Radiopharmaceuticals Consumption by Region
2.2.1 World Therapeutic Radiopharmaceuticals Consumption by Region (2018-2023)
2.2.2 World Therapeutic Radiopharmaceuticals Consumption Forecast by Region (2024-2029)
2.3 United States Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.4 China Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.5 Europe Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.6 Japan Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.7 South Korea Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.8 ASEAN Therapeutic Radiopharmaceuticals Consumption (2018-2029)
2.9 India Therapeutic Radiopharmaceuticals Consumption (2018-2029)

3 World Therapeutic Radiopharmaceuticals Manufacturers Competitive Analysis
3.1 World Therapeutic Radiopharmaceuticals Production Value by Manufacturer (2018-2023)
3.2 World Therapeutic Radiopharmaceuticals Production by Manufacturer (2018-2023)
3.3 World Therapeutic Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 Therapeutic Radiopharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Therapeutic Radiopharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Therapeutic Radiopharmaceuticals in 2022
3.5.3 Global Concentration Ratios (CR8) for Therapeutic Radiopharmaceuticals in 2022
3.6 Therapeutic Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 Therapeutic Radiopharmaceuticals Market: Region Footprint
3.6.2 Therapeutic Radiopharmaceuticals Market: Company Product Type Footprint
3.6.3 Therapeutic Radiopharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Therapeutic Radiopharmaceuticals Production Value Comparison
4.1.1 United States VS China: Therapeutic Radiopharmaceuticals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Therapeutic Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Therapeutic Radiopharmaceuticals Production Comparison
4.2.1 United States VS China: Therapeutic Radiopharmaceuticals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Therapeutic Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Therapeutic Radiopharmaceuticals Consumption Comparison
4.3.1 United States VS China: Therapeutic Radiopharmaceuticals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Therapeutic Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Therapeutic Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Value (2018-2023)
4.4.3 United States Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023)
4.5 China Based Therapeutic Radiopharmaceuticals Manufacturers and Market Share
4.5.1 China Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Therapeutic Radiopharmaceuticals Production Value (2018-2023)
4.5.3 China Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023)
4.6 Rest of World Based Therapeutic Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023)

5 Market Analysis by Type
5.1 World Therapeutic Radiopharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Radium-223
5.2.2 Lutetium-177
5.2.3 Iodine-131
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Therapeutic Radiopharmaceuticals Production by Type (2018-2029)
5.3.2 World Therapeutic Radiopharmaceuticals Production Value by Type (2018-2029)
5.3.3 World Therapeutic Radiopharmaceuticals Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Therapeutic Radiopharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Thyroid
6.2.2 Bone Metastasis
6.2.3 Lymphoma
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Therapeutic Radiopharmaceuticals Production by Application (2018-2029)
6.3.2 World Therapeutic Radiopharmaceuticals Production Value by Application (2018-2029)
6.3.3 World Therapeutic Radiopharmaceuticals Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Therapeutic Radiopharmaceuticals Product and Services
7.1.4 Bayer Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Therapeutic Radiopharmaceuticals Product and Services
7.2.4 Novartis Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Details
7.3.2 China Isotope & Radiation Major Business
7.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
7.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 China Isotope & Radiation Recent Developments/Updates
7.3.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.4 Dongcheng
7.4.1 Dongcheng Details
7.4.2 Dongcheng Major Business
7.4.3 Dongcheng Therapeutic Radiopharmaceuticals Product and Services
7.4.4 Dongcheng Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Dongcheng Recent Developments/Updates
7.4.6 Dongcheng Competitive Strengths & Weaknesses
7.5 Q BioMed
7.5.1 Q BioMed Details
7.5.2 Q BioMed Major Business
7.5.3 Q BioMed Therapeutic Radiopharmaceuticals Product and Services
7.5.4 Q BioMed Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Q BioMed Recent Developments/Updates
7.5.6 Q BioMed Competitive Strengths & Weaknesses
7.6 Curium Pharmaceuticals
7.6.1 Curium Pharmaceuticals Details
7.6.2 Curium Pharmaceuticals Major Business
7.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
7.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Curium Pharmaceuticals Recent Developments/Updates
7.6.6 Curium Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Jubilant Radiopharma
7.7.1 Jubilant Radiopharma Details
7.7.2 Jubilant Radiopharma Major Business
7.7.3 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product and Services
7.7.4 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Jubilant Radiopharma Recent Developments/Updates
7.7.6 Jubilant Radiopharma Competitive Strengths & Weaknesses
7.8 Lantheus
7.8.1 Lantheus Details
7.8.2 Lantheus Major Business
7.8.3 Lantheus Therapeutic Radiopharmaceuticals Product and Services
7.8.4 Lantheus Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Lantheus Recent Developments/Updates
7.8.6 Lantheus Competitive Strengths & Weaknesses
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Details
7.9.2 Aurobindo Pharma Major Business
7.9.3 Aurobindo Pharma Therapeutic Radiopharmaceuticals Product and Services
7.9.4 Aurobindo Pharma Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Aurobindo Pharma Recent Developments/Updates
7.9.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.10 International Isotopes
7.10.1 International Isotopes Details
7.10.2 International Isotopes Major Business
7.10.3 International Isotopes Therapeutic Radiopharmaceuticals Product and Services
7.10.4 International Isotopes Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 International Isotopes Recent Developments/Updates
7.10.6 International Isotopes Competitive Strengths & Weaknesses
7.11 Mundipharma
7.11.1 Mundipharma Details
7.11.2 Mundipharma Major Business
7.11.3 Mundipharma Therapeutic Radiopharmaceuticals Product and Services
7.11.4 Mundipharma Therapeutic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Mundipharma Recent Developments/Updates
7.11.6 Mundipharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Therapeutic Radiopharmaceuticals Industry Chain
8.2 Therapeutic Radiopharmaceuticals Upstream Analysis
8.2.1 Therapeutic Radiopharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of Therapeutic Radiopharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Therapeutic Radiopharmaceuticals Production Mode
8.6 Therapeutic Radiopharmaceuticals Procurement Model
8.7 Therapeutic Radiopharmaceuticals Industry Sales Model and Sales Channels
8.7.1 Therapeutic Radiopharmaceuticals Sales Model
8.7.2 Therapeutic Radiopharmaceuticals Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Therapeutic Radiopharmaceuticals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Therapeutic Radiopharmaceuticals Production Value by Region (2018-2023) & (USD Million)
Table 3. World Therapeutic Radiopharmaceuticals Production Value by Region (2024-2029) & (USD Million)
Table 4. World Therapeutic Radiopharmaceuticals Production Value Market Share by Region (2018-2023)
Table 5. World Therapeutic Radiopharmaceuticals Production Value Market Share by Region (2024-2029)
Table 6. World Therapeutic Radiopharmaceuticals Production by Region (2018-2023) & (K Units)
Table 7. World Therapeutic Radiopharmaceuticals Production by Region (2024-2029) & (K Units)
Table 8. World Therapeutic Radiopharmaceuticals Production Market Share by Region (2018-2023)
Table 9. World Therapeutic Radiopharmaceuticals Production Market Share by Region (2024-2029)
Table 10. World Therapeutic Radiopharmaceuticals Average Price by Region (2018-2023) & (USD/Unit)
Table 11. World Therapeutic Radiopharmaceuticals Average Price by Region (2024-2029) & (USD/Unit)
Table 12. Therapeutic Radiopharmaceuticals Major Market Trends
Table 13. World Therapeutic Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Therapeutic Radiopharmaceuticals Consumption by Region (2018-2023) & (K Units)
Table 15. World Therapeutic Radiopharmaceuticals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Therapeutic Radiopharmaceuticals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Therapeutic Radiopharmaceuticals Producers in 2022
Table 18. World Therapeutic Radiopharmaceuticals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Therapeutic Radiopharmaceuticals Producers in 2022
Table 20. World Therapeutic Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 21. Global Therapeutic Radiopharmaceuticals Company Evaluation Quadrant
Table 22. World Therapeutic Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Therapeutic Radiopharmaceuticals Production Site of Key Manufacturer
Table 24. Therapeutic Radiopharmaceuticals Market: Company Product Type Footprint
Table 25. Therapeutic Radiopharmaceuticals Market: Company Product Application Footprint
Table 26. Therapeutic Radiopharmaceuticals Competitive Factors
Table 27. Therapeutic Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. Therapeutic Radiopharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China Therapeutic Radiopharmaceuticals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Therapeutic Radiopharmaceuticals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Therapeutic Radiopharmaceuticals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share (2018-2023)
Table 37. China Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share (2018-2023)
Table 42. Rest of World Based Therapeutic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share (2018-2023)
Table 47. World Therapeutic Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Therapeutic Radiopharmaceuticals Production by Type (2018-2023) & (K Units)
Table 49. World Therapeutic Radiopharmaceuticals Production by Type (2024-2029) & (K Units)
Table 50. World Therapeutic Radiopharmaceuticals Production Value by Type (2018-2023) & (USD Million)
Table 51. World Therapeutic Radiopharmaceuticals Production Value by Type (2024-2029) & (USD Million)
Table 52. World Therapeutic Radiopharmaceuticals Average Price by Type (2018-2023) & (USD/Unit)
Table 53. World Therapeutic Radiopharmaceuticals Average Price by Type (2024-2029) & (USD/Unit)
Table 54. World Therapeutic Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Therapeutic Radiopharmaceuticals Production by Application (2018-2023) & (K Units)
Table 56. World Therapeutic Radiopharmaceuticals Production by Application (2024-2029) & (K Units)
Table 57. World Therapeutic Radiopharmaceuticals Production Value by Application (2018-2023) & (USD Million)
Table 58. World Therapeutic Radiopharmaceuticals Production Value by Application (2024-2029) & (USD Million)
Table 59. World Therapeutic Radiopharmaceuticals Average Price by Application (2018-2023) & (USD/Unit)
Table 60. World Therapeutic Radiopharmaceuticals Average Price by Application (2024-2029) & (USD/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Therapeutic Radiopharmaceuticals Product and Services
Table 64. Bayer Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Therapeutic Radiopharmaceuticals Product and Services
Table 70. Novartis Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 74. China Isotope & Radiation Major Business
Table 75. China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
Table 76. China Isotope & Radiation Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. China Isotope & Radiation Recent Developments/Updates
Table 78. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 79. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 80. Dongcheng Major Business
Table 81. Dongcheng Therapeutic Radiopharmaceuticals Product and Services
Table 82. Dongcheng Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Dongcheng Recent Developments/Updates
Table 84. Dongcheng Competitive Strengths & Weaknesses
Table 85. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 86. Q BioMed Major Business
Table 87. Q BioMed Therapeutic Radiopharmaceuticals Product and Services
Table 88. Q BioMed Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Q BioMed Recent Developments/Updates
Table 90. Q BioMed Competitive Strengths & Weaknesses
Table 91. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Curium Pharmaceuticals Major Business
Table 93. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 94. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Curium Pharmaceuticals Recent Developments/Updates
Table 96. Curium Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Jubilant Radiopharma Basic Information, Manufacturing Base and Competitors
Table 98. Jubilant Radiopharma Major Business
Table 99. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product and Services
Table 100. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Jubilant Radiopharma Recent Developments/Updates
Table 102. Jubilant Radiopharma Competitive Strengths & Weaknesses
Table 103. Lantheus Basic Information, Manufacturing Base and Competitors
Table 104. Lantheus Major Business
Table 105. Lantheus Therapeutic Radiopharmaceuticals Product and Services
Table 106. Lantheus Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Lantheus Recent Developments/Updates
Table 108. Lantheus Competitive Strengths & Weaknesses
Table 109. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Aurobindo Pharma Major Business
Table 111. Aurobindo Pharma Therapeutic Radiopharmaceuticals Product and Services
Table 112. Aurobindo Pharma Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Aurobindo Pharma Recent Developments/Updates
Table 114. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 115. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 116. International Isotopes Major Business
Table 117. International Isotopes Therapeutic Radiopharmaceuticals Product and Services
Table 118. International Isotopes Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. International Isotopes Recent Developments/Updates
Table 120. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 121. Mundipharma Major Business
Table 122. Mundipharma Therapeutic Radiopharmaceuticals Product and Services
Table 123. Mundipharma Therapeutic Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Therapeutic Radiopharmaceuticals Upstream (Raw Materials)
Table 125. Therapeutic Radiopharmaceuticals Typical Customers
Table 126. Therapeutic Radiopharmaceuticals Typical Distributors
List of Figure
Figure 1. Therapeutic Radiopharmaceuticals Picture
Figure 2. World Therapeutic Radiopharmaceuticals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Therapeutic Radiopharmaceuticals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 5. World Therapeutic Radiopharmaceuticals Average Price (2018-2029) & (USD/Unit)
Figure 6. World Therapeutic Radiopharmaceuticals Production Value Market Share by Region (2018-2029)
Figure 7. World Therapeutic Radiopharmaceuticals Production Market Share by Region (2018-2029)
Figure 8. North America Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 9. Europe Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 10. China Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 11. Japan Therapeutic Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 12. Therapeutic Radiopharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 15. World Therapeutic Radiopharmaceuticals Consumption Market Share by Region (2018-2029)
Figure 16. United States Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 17. China Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 18. Europe Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 19. Japan Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 20. South Korea Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 22. India Therapeutic Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Therapeutic Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Therapeutic Radiopharmaceuticals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Therapeutic Radiopharmaceuticals Markets in 2022
Figure 26. United States VS China: Therapeutic Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Therapeutic Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Therapeutic Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share 2022
Figure 30. China Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Therapeutic Radiopharmaceuticals Production Market Share 2022
Figure 32. World Therapeutic Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Therapeutic Radiopharmaceuticals Production Value Market Share by Type in 2022
Figure 34. Radium-223
Figure 35. Lutetium-177
Figure 36. Iodine-131
Figure 37. Other
Figure 38. World Therapeutic Radiopharmaceuticals Production Market Share by Type (2018-2029)
Figure 39. World Therapeutic Radiopharmaceuticals Production Value Market Share by Type (2018-2029)
Figure 40. World Therapeutic Radiopharmaceuticals Average Price by Type (2018-2029) & (USD/Unit)
Figure 41. World Therapeutic Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Therapeutic Radiopharmaceuticals Production Value Market Share by Application in 2022
Figure 43. Thyroid
Figure 44. Bone Metastasis
Figure 45. Lymphoma
Figure 46. Other
Figure 47. World Therapeutic Radiopharmaceuticals Production Market Share by Application (2018-2029)
Figure 48. World Therapeutic Radiopharmaceuticals Production Value Market Share by Application (2018-2029)
Figure 49. World Therapeutic Radiopharmaceuticals Average Price by Application (2018-2029) & (USD/Unit)
Figure 50. Therapeutic Radiopharmaceuticals Industry Chain
Figure 51. Therapeutic Radiopharmaceuticals Procurement Model
Figure 52. Therapeutic Radiopharmaceuticals Sales Model
Figure 53. Therapeutic Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
jiaGou

Add To Cart

gouMai

Buy Now